08:41 AM EDT, 10/07/2024 (MT Newswires) -- Dana Pizzuti, Chief Med and Dev Officer, on October 03, 2024, sold 14,375 shares in Crinetics Pharmaceuticals ( CRNX ) for $785,306. Following the Form 4 filing with the SEC, Pizzuti has control over a total of 28,507 shares of the company, with 28,507 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000095017024113082/xslF345X05/ownership.xml

Price: 54.00, Change: +0.86, Percent Change: +1.62